Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Vulto, A.
776  Ergebnisse:
Personensuche X
?
1

HPR59 Evolving Global Regulatory Landscape for Approval of ..:

Car, E.S. ; Barbier, L. ; Vulto, A...
Value in Health.  26 (2023)  12 - p. S263-S264 , 2023
Link: https://doi.org/10.1016/..
 
?
2

HSD19 Which Elements Determine Prescribing Decisions for Of..:

Vandenplas, Y ; Simoens, S ; Van Wilder, P...
Value in Health.  25 (2022)  12 - p. S276-S277 , 2022
Link: https://doi.org/10.1016/..
 
?
3

POSC223 Realising the Full Potential of Benefit-Sharing Pro..:

Barcina, T ; Vulto, A ; Turcu-Stiolica, A..
Value in Health.  25 (2022)  1 - p. S151 , 2022
Link: https://doi.org/10.1016/..
 
?
4

HPR116 The Impact of Policy Measures to Increase the Uptake..:

Vandenplas, Y ; Simoens, S ; Van Wilder, P..
Value in Health.  25 (2022)  12 - p. S253 , 2022
Link: https://doi.org/10.1016/..
 
?
5

HPR52 TNF-Alfa Inhibitor Therapies: Evaluating the Impact o..:

Barcina, T ; Vulto, A ; Huys, I.
Value in Health.  25 (2022)  12 - p. S242 , 2022
Link: https://doi.org/10.1016/..
 
?
6

POSB382 Perceptions about Biosimilar Medicines Among Belgia..:

Vandenplas, Y ; Barbier, L ; Simoens, S...
Value in Health.  25 (2022)  1 - p. S235 , 2022
Link: https://doi.org/10.1016/..
 
?
7

HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis..:

Barcina, T ; Vulto, A ; Huys, I.
Value in Health.  25 (2022)  12 - p. S258 , 2022
Link: https://doi.org/10.1016/..
 
?
8

HPR23 A Comparative Analysis of Biosimilar Competition in E..:

Car, E ; Vulto, A ; Huys, I..
Value in Health.  25 (2022)  12 - p. S236 , 2022
Link: https://doi.org/10.1016/..
 
?
9

PBI40 Tendering of Off-Patent Biologicals and Biosimilars: ..:

Barbier, L. ; Simoens, S. ; Vulto, A..
Value in Health.  23 (2020)  - p. S417 , 2020
Link: https://doi.org/10.1016/..
 
?
10

PBI32 Fulfilling the Potential of Best-VALUE Biological Med..:

Vandenplas, Y. ; Simoens, S. ; Van Wilder, P...
Value in Health.  23 (2020)  - p. S415-S416 , 2020
Link: https://doi.org/10.1016/..
 
?
11

PBI54 The Role of Patient Education about Biosimilar Medici..:

Vandenplas, Y. ; Brown, J. ; Janssens, B....
Value in Health.  23 (2020)  - p. S419 , 2020
Link: https://doi.org/10.1016/..
 
?
12

PBI27 Multistakeholder Recommendations for LONG-TERM Sustai..:

Vulto, A. ; Vanderpuye-Orgle, J. ; van der Graaff, M....
Value in Health.  23 (2020)  - p. S415 , 2020
Link: https://doi.org/10.1016/..
 
?
13

PBI37 Infliximab and Etanercept Biosimilars and Originators..:

Barcina, T. ; Moorkens, E. ; Vulto, A....
Value in Health.  23 (2020)  - p. S416 , 2020
Link: https://doi.org/10.1016/..
 
?
14

PNS151 THE ROLE OF REGULATORY GUIDANCE AND INFORMATION DISS..:

Barbier, L. ; Mbuaki, A. ; Simoens, S...
Value in Health.  22 (2019)  - p. S786-S787 , 2019
Link: https://doi.org/10.1016/..
 
?
15

PBI54 BIOSIMILAR AND ORIGINATOR INFLIXIMAB AND ETANERCEPT: ..:

Moorkens, E. ; Vulto, A. ; Simoens, S..
Value in Health.  22 (2019)  - p. S427 , 2019
Link: https://doi.org/10.1016/..
 
1-15